"En 1959, le Professeur Jérôme Lejeune, médecin et chercheur, a découvert l’origine génétique de la trisomie 21. A sa suite, la Fondation Jérôme Lejeune, reconnue d’utilité publique depuis 1996, agit pour les personnes atteintes de maladie génétique de l’intelligence (trisomie 21 , Williams-Beuren, X-fragile, maladie du cri du chat, autres trisomies, monosomies, retards mentaux inexpliqués…), en recevant avec l'Institut Jérôme Lejeune près de 10 000 patients tous les ans et en finançant de nombreux programmes de recherches scientifiques."

During the past decade, Institut Jérome Lejeune conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jérome Lejeune" #1 collaborator was "Fondation Jérôme Lejeune" with 4 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "Central Hospital, Nancy, France" with 1 trials as a collaborator and "Hôpital Cochin" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Institut Jérome Lejeune" are "Down Syndrome" (7 trials), "Alzheimer Disease" (2 trials), "Dementia" (1 trials), "Down Syndrome With and Without Auto Immune Abnormalities" (1 trials) and "Obstructive Sleep Apnea Syndrome" (1 trials). Many other conditions were trialed in "Institut Jérome Lejeune" in a lesser frequency.

Most popular intervention types in "Institut Jérome Lejeune" are "Drug" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Continuous Positive Pressure" (1 trials), "Flutafuranol" (1 trials), "MK6240" (1 trials), "Neuro-imaging, Lumbar puncture" (1 trials) and "Pittsburgh Compound (PIB)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jérome Lejeune" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Institut Jérome Lejeune". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Institut Jérome Lejeune, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jérome Lejeune, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".